Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry
Rigshospitalet, Copenhagen, Denmark
Rigshospitalet, Copenhagen, Denmark
Hôpital Universitaire Paul Brousse, Villejuif, France
National Institute of Public Health, Copenhagen, Denmark
A.O.U. Città
della Salute e della Scienza di Torino, Turin, Italy
Hospital Virgen del Rocio, Sevilla, Spain
Hôpital Universitaire Paul Brousse, Villejuif, France
University of Pisa Medical School Hospital, Pisa, Italy
Hôpital Pontchaillou, Rennes, France
Istituto Nazionale Tumori, Milan, Italy
Beaujon Hospital, Clichy, France
Hospital Clínic, Barcelona, Spain
Hospital Universitari de Bellvitge, Barcelona, Spain
S. Orsola Hospital, Bologna, Italy
King's College Hospital, London, United Kingdom
Hôpital Universitaire Paul Brousse, Villejuif, France
Henri Mondor Hospital, Créteil, France
Rigshospitalet, Copnehagen, Denmark.
Meeting: 2018 American Transplant Congress
Abstract number: B274
Keywords: Hepatocellular carcinoma
Session Information
Session Name: Poster Session B: Liver: Hepatocellular Carcinoma and Other Malignancies
Session Type: Poster Session
Date: Sunday, June 3, 2018
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall 4EF
Purpose
Studies suggest that vascular invasion may be a superior prognostic marker compared with traditional selection criteria, e.g. Milan criteria. We aimed to investigate the prognostic value of vascular invasion in a large database material.
Methods
We included patients liver transplanted for HCC and cirrhosis registered in the European Liver Transplant Registry (ELTR) database. The association between the Milan criteria, Up-to-seven criteria and vascular invasion with overall survival and HCC specific survival was investigated with univariate and multivariate Cox regression analyses.
Results
Of 23,124 patients transplanted for HCC, 9,324 had cirrhosis and data on explant pathology. Patients without microvascular invasion, regardless of number and size of HCC nodules, had a five-year overall survival of 73.2%, which was comparable with patients inside both Milan and Up-to-seven criteria. Patients without macrovascular invasion had an only marginally reduced survival of 70.7% after five years. Patients outside both Milan and Up-to-seven criteria without vascular invasion still had a five-year overall survival of 65.8%.
Discussion
Vascular invasion as a prognostic indicator remains superior to criteria based on size and number of nodules. With continuously improving imaging studies, vascular invasion may be used for selecting patients for transplantation in the future.
CITATION INFORMATION: Pommergaard H-.C., Rostved A., Adam R., Thygesen L., Salizzoni M., Bravo M., Cherqui D., Filipponi F., Boudjema K., Mazzaferro V., Soubrane O., García-Valdecasas J., Prous J., Pinna A., O'Grady J., Karam V., Duvoux C., Rasmussen A. Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:
Pommergaard H-C, Rostved A, Adam R, Thygesen L, Salizzoni M, Bravo M, Cherqui D, Filipponi F, Boudjema K, Mazzaferro V, Soubrane O, García-Valdecasas J, Prous J, Pinna A, O'Grady J, Karam V, Duvoux C, Rasmussen A. Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry [abstract]. https://atcmeetingabstracts.com/abstract/vascular-invasion-and-survival-after-liver-transplantation-for-hepatocellular-carcinoma-a-study-from-the-european-liver-transplant-registry/. Accessed November 23, 2024.« Back to 2018 American Transplant Congress